2nd December 2020
In this proof-of-concept study evidence is provided of the clinical potential of base editors for the correction of mutations causing inherited retinal diseases and for restoring visual function. Following the optimization of the base-editing outcome using an in vitro system, the base-editing strategy was translated to a mouse model and showed a substantial level of vision restoration.